It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the U.S. – his administration’s bid to boost manufacturing in the country.
Related Posts
Arm Holdings can climb 20% after earnings beat, Loop Capital says
The firm raised its price target and reiterated its buy rating.
Weekly mortgage demand drops 6%, as homebuyers remain ‘on the fence’
Mortgage rates dipped slightly last week, but so did mortgage demand, as housing affordability continues to sideline potential buyers.
This software AI play is breaking down and in for more pain, according to the charts
David Keller breaks down the charts in ServiceNow.